JPWO2019191026A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019191026A5 JPWO2019191026A5 JP2020551992A JP2020551992A JPWO2019191026A5 JP WO2019191026 A5 JPWO2019191026 A5 JP WO2019191026A5 JP 2020551992 A JP2020551992 A JP 2020551992A JP 2020551992 A JP2020551992 A JP 2020551992A JP WO2019191026 A5 JPWO2019191026 A5 JP WO2019191026A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- rna virus
- keratitis
- related disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023035224A JP2023071933A (ja) | 2018-03-27 | 2023-03-08 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862648585P | 2018-03-27 | 2018-03-27 | |
| US62/648,585 | 2018-03-27 | ||
| US201862693021P | 2018-07-02 | 2018-07-02 | |
| US62/693,021 | 2018-07-02 | ||
| PCT/US2019/023977 WO2019191026A2 (en) | 2018-03-27 | 2019-03-26 | Methods for the use of 5'-adenosine diphosphate ribose (adpr) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023035224A Division JP2023071933A (ja) | 2018-03-27 | 2023-03-08 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021519315A JP2021519315A (ja) | 2021-08-10 |
| JPWO2019191026A5 true JPWO2019191026A5 (ko) | 2022-04-01 |
| JP7242696B2 JP7242696B2 (ja) | 2023-03-20 |
Family
ID=66647439
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551992A Active JP7242696B2 (ja) | 2018-03-27 | 2019-03-26 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
| JP2023035224A Pending JP2023071933A (ja) | 2018-03-27 | 2023-03-08 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023035224A Pending JP2023071933A (ja) | 2018-03-27 | 2023-03-08 | ５’－アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US10946034B2 (ko) |
| EP (2) | EP3773604B1 (ko) |
| JP (2) | JP7242696B2 (ko) |
| ES (1) | ES2949441T3 (ko) |
| WO (1) | WO2019191026A2 (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6946353B2 (ja) | 2016-02-18 | 2021-10-06 | インバーサ， インコーポレイテッド | ５′−アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
| ES2949441T3 (es) | 2018-03-27 | 2023-09-28 | Invirsa Inc | Métodos para el uso de 5'-adenosina difosfato ribosa (ADPR) |
| CN111714619B (zh) * | 2020-07-15 | 2023-03-14 | 上海市浦东新区人民医院 | 成纤维生长因子6在制备缓解非酒精性脂肪性肝炎肝损伤的药物中的应用 |
| CN112972453B (zh) * | 2021-03-05 | 2022-04-15 | 中国人民解放军军事科学院军事医学研究院 | MDL-800在制备抑制SARS-CoV-2病毒易感性药物中的应用 |
| KR20230036274A (ko) * | 2021-09-07 | 2023-03-14 | 정근영 | 방사선 및/또는 항암 치료 보조 요법으로 아데노신 디포스페이트 리보오스의 활용 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04273826A (ja) * | 1991-02-27 | 1992-09-30 | Dainippon Ink & Chem Inc | 抗ｒｓウイルス剤 |
| EP0618214A1 (en) | 1993-04-01 | 1994-10-05 | Merrell Dow Pharmaceuticals Inc. | Unsaturated phosphonate derivatives of purines and pyrimidines |
| JPH07247210A (ja) | 1994-03-09 | 1995-09-26 | Sunstar Inc | 口腔用組成物 |
| AU744902B2 (en) | 1997-09-11 | 2002-03-07 | Oxigene, Inc. | Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
| US6331529B1 (en) | 1999-02-26 | 2001-12-18 | Inspire Pharmaceuticals, Inc. | Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof |
| WO2000077179A2 (en) | 1999-06-16 | 2000-12-21 | Icos Corporation | Human poly(adp-ribose) polymerase 2 materials and methods |
| US6528042B1 (en) | 1999-10-08 | 2003-03-04 | Galileo Laboratories, Inc. | Compositions of flavonoids for use as cytoprotectants and methods of making and using them |
| US7115585B2 (en) | 2000-08-21 | 2006-10-03 | Inspire Pharmaceuticals, Inc. | Compositions for treating epithelial and retinal tissue diseases |
| WO2003011885A1 (en) | 2001-07-25 | 2003-02-13 | Celltech R & D Limited | Non-natural carbon-linked nucleotides and dinucleotides |
| WO2003099297A1 (en) * | 2002-05-21 | 2003-12-04 | Abbott Laboratories | Treatment of mucositis |
| JP2005089450A (ja) * | 2003-08-11 | 2005-04-07 | Fujisawa Pharmaceut Co Ltd | Ｒｓウィルスによる感染症の予防または治療剤 |
| US20070212395A1 (en) | 2006-03-08 | 2007-09-13 | Allergan, Inc. | Ocular therapy using sirtuin-activating agents |
| US20050276762A1 (en) * | 2004-06-15 | 2005-12-15 | Tapas Das | Topical compositions containing 5'-adenosine-diphosphate ribose |
| EP1928440A2 (en) | 2005-05-25 | 2008-06-11 | Sirtris Pharmaceuticals, Inc. | Treatment of eye disorders with sirtuin modulators |
| WO2007054814A1 (en) | 2005-11-14 | 2007-05-18 | Centre National De La Recherche Scientifique - Cnrs | Inhibitors of parp activity and uses thereof |
| WO2008154129A1 (en) | 2007-06-08 | 2008-12-18 | Bausch & Lomb Incorporated | Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye |
| US20110217262A1 (en) | 2010-03-05 | 2011-09-08 | Kornfield Julia A | Treatment of Ocular Surface Disorders by Increasing Conjunctival Vascular Permeability |
| CA2798697A1 (en) | 2010-05-10 | 2011-11-17 | Radikal Therapeutics Inc. | Lipoic acid and nitroxide derivatives and uses thereof |
| EP2707006B1 (en) | 2011-05-12 | 2019-07-03 | Foresight Biotherapeutics, Inc. | Stable povidone-iodine compositions with bromfenac |
| US20160287622A1 (en) * | 2013-11-18 | 2016-10-06 | Massachusetts Institute Of Technology | Compositions and methods for treating immune and viral disorders and modulating protein-rna interaction |
| JP6946353B2 (ja) | 2016-02-18 | 2021-10-06 | インバーサ， インコーポレイテッド | ５′−アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 |
| ES2949441T3 (es) | 2018-03-27 | 2023-09-28 | Invirsa Inc | Métodos para el uso de 5'-adenosina difosfato ribosa (ADPR) |
-
2019
- 2019-03-26 ES ES19726521T patent/ES2949441T3/es active Active
- 2019-03-26 US US16/364,760 patent/US10946034B2/en active Active
- 2019-03-26 JP JP2020551992A patent/JP7242696B2/ja active Active
- 2019-03-26 EP EP19726521.8A patent/EP3773604B1/en active Active
- 2019-03-26 WO PCT/US2019/023977 patent/WO2019191026A2/en unknown
- 2019-03-26 EP EP23168073.7A patent/EP4226971A1/en active Pending
-
2021
- 2021-02-09 US US17/171,548 patent/US11793826B2/en active Active
-
2023
- 2023-03-08 JP JP2023035224A patent/JP2023071933A/ja active Pending
- 2023-09-11 US US18/244,693 patent/US20230414647A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5972904A (en) | Method of treating sinusitis with uridine triphosphates and related compounds | |
| EP0938322B1 (en) | Use of uridine triphosphate related compounds for the prevention and treatment of pneumonia in immobilized patients | |
| US6423694B1 (en) | Method of treating otitis media with uridine triphosphates and related compounds | |
| EP0889728B1 (en) | Method of treating ciliary dyskinesia with uridine triphosphates and related compounds | |
| ES2222294T3 (es) | Formulacion optimizada de tobramicina para administracion en forma de aerosol. | |
| EP0941099B1 (en) | Treatment of bronchitis with diuridine tetraphosphate | |
| JP2023071933A5 (ko) | ||
| CN101495122A (zh) | 使用定量吸入器给予曲前列尼 | |
| JP2014518268A5 (ko) | ||
| JP2009500354A (ja) | 肺疾患を治療するためのｐ２ｙ６受容体アゴニスト | |
| BR112018074551B1 (pt) | Aerossol farmacêutico, composições farmacêuticas líquida e sólida, kit, e, método para preparar e dispensar um aerossol | |
| RU2015129076A (ru) | Арилалкил- и арилоксиалкил-замещенные соединения, блокирующие эпителиальный натриевый канал | |
| JPWO2019191026A5 (ko) | ||
| JP2019505596A5 (ko) | ||
| HRP20211942T1 (hr) | Medicinska uporaba 5'-adenozin difosfat riboze (adpr) | |
| TW202042813A (zh) | 含有白三烯受體拮抗劑的新穎調配物 | |
| CA2701388C (en) | Calcium glycerophosphate for treating and preventing respiratory diseases or conditions | |
| EP1941883A1 (en) | Use of sodium blockers for an early therapy of obstructive lung diseases | |
| KR100549904B1 (ko) | 우리딘트리포스페이트및관련화합물을함유하는섬모운동장해치료용약학조성물 | |
| CA3202852A1 (en) | Methods and compositions for treating chronic obstructive pulmonary disease, asthma, pneumonia, bronchitis, cystic fibrosis and pulmonary edema, interstitial lung disease, sarcoidosis, idiopathic pulmonary fibrosis, a cute respiratory distress syndrome, and pulmonary arterial hypertension | |
| IT202000012343A1 (it) | Metotrexato per l’uso nel trattamento farmaceutico di infezioni virali del tratto respiratorio | |
| TW505517B (en) | Novel pharmaceutical compositions of uridine triphosphate | |
| JPWO2021222740A5 (ko) | ||
| MXPA99000011A (en) | Method for treating sinusitis with trifosphates deuridine and relative compounds |